Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.

Lung - 1 Apr 2020

Sagwal Swati, Chauhan Anil, Kaur Jyotdeep, Prasad Rajendra, Singh Meenu, Singh Manvi

Abstract excerpt

PURPOSE: Cystic Fibrosis (CF) is a multi-organ genetic disorder and Transforming Growth Factor (TGF-β1) is a modifier gene which modulates lung pathology in CF. There is great phenotypic variability among CF patients who even have similar genotype. The aim of the present study was to associate the serum levels of TGF-β1 with several clinical phenotypes of CF. METHODS: The diagnosed cases of CF were recruited and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Biomarkers
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Disease Progression

Share to Enzyme-Linked Immunosorbent Assay

Share to Pseudomonas Infections

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 31919585
DOI: 10.1007/s00408-020-00320-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.PMID 31919585Read ↗

The Effect of TGF-β1 Polymorphisms on Pulmonary Disease Progression in Patients with Cystic FibrosisSemantic proximity Read ↗

Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.Semantic proximity Read ↗

The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis.Semantic proximity Read ↗

Role of the TGF-β cytokine and its gene polymorphisms in asthma etiopathogenesisSemantic proximity Read ↗

Transforming growth factor-β1 as a biomarker in COPD patients with pulmonary fibrosisSemantic proximity Read ↗

Association of TGFB1 -509C/T polymorphism gene with clinical variability in cystic fibrosis patients: A case-control study.Semantic proximity Read ↗

The effect of TGF-beta1 polymorphisms on pulmonary disease progression in patients with cystic fibrosisSemantic proximity Read ↗

TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen.Semantic proximity Read ↗

Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis.Semantic proximity Read ↗

Controversy surrounding the increased expression of TGFβ1 in asthmaSemantic proximity Read ↗

TGFB1 Gene Promoter Polymorphisms in Serbian Asthmatics.Semantic proximity Read ↗

Association of transforming growth factor-Beta 1 promoter variant -509 c/t with bronchial asthma in South Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.